Arrhythmogenic Cardiomyopathy Panel Test code: 02263 • 10–21 days turnaround time Up to 27 genes
Arrhythmogenic Cardiomyopathy Panel
This panel provides a comprehensive genetic analysis of genes associated with inherited cardiomyopathy conditions that have a prominent arrhythmia phenotype or may present with cardiac arrhythmias before the development of cardiomyopathy.
Because different arrhythmogenic cardiomyopathy conditions can have significant clinical and genetic overlap, comprehensive panel testing allows for an efficient evaluation of multiple potential genetic causes based on a single clinical indication.
Individuals with symptoms or clinical findings suggestive of arrhythmogenic cardiomyopathy may benefit from diagnostic genetic testing. Testing may help to:
- Establish or confirm a clinical diagnosis
- Identify an underlying inherited genetic cause
- Clarify potential cardiac and arrhythmia risks
- Guide individualized medical management
- Support appropriate cardiac monitoring and surveillance
- Inform risk-reduction strategies
- Provide information for genetic counseling and family testing
Family Testing:
Asymptomatic individuals with a family history of arrhythmogenic cardiomyopathy or a known familial pathogenic variant may also benefit from targeted genetic testing. Identifying individuals who carry a pathogenic variant may help clarify their personal risk and support appropriate clinical evaluation, monitoring, and management.
Genetic information may also help individuals and their healthcare professionals make informed decisions regarding activities, medications, and other factors that could potentially trigger symptoms or increase the risk of cardiac arrhythmias.
Important: Activity and medication decisions should be made in consultation with a qualified healthcare professional and interpreted in the context of the individual's clinical history, family history, and other cardiac findings.